BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38525552)

  • 1. Cystic Features in Renal Epithelial Neoplasms and Their Increasing Clinical and Pathologic Significance.
    Tretiakova M; Kwon JW; Paner GP
    Adv Anat Pathol; 2024 May; 31(3):157-168. PubMed ID: 38525552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classification.
    Honda Y; Goto K; Nakamura Y; Terada H; Sentani K; Yasui W; Sekino Y; Hayashi T; Teishima J; Matsubara A; Fuji T; Kaichi Y; Higaki T; Baba Y; Iida M; Awai K
    Abdom Radiol (NY); 2017 Jul; 42(7):1850-1856. PubMed ID: 28534069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.
    Tickoo SK; dePeralta-Venturina MN; Harik LR; Worcester HD; Salama ME; Young AN; Moch H; Amin MB
    Am J Surg Pathol; 2006 Feb; 30(2):141-53. PubMed ID: 16434887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear Cell Papillary Renal Cell Carcinoma: A Recent Entity With Distinct Imaging Patterns.
    Tordjman M; Dbjay J; Chamouni A; Morini A; Timsit MO; Mejean A; Vasiliu V; Eiss D; Correas JM; Verkarre V; Helenon O
    AJR Am J Roentgenol; 2020 Mar; 214(3):579-587. PubMed ID: 31770020
    [No Abstract]   [Full Text] [Related]  

  • 5. Multilocular cystic renal cell carcinoma: comparison of imaging and pathologic findings.
    Hindman NM; Bosniak MA; Rosenkrantz AB; Lee-Felker S; Melamed J
    AJR Am J Roentgenol; 2012 Jan; 198(1):W20-6. PubMed ID: 22194510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACD-RCC): A Multiinstitutional Study of 40 Cases With Clinical Follow-up.
    Przybycin CG; Harper HL; Reynolds JP; Magi-Galluzzi C; Nguyen JK; Wu A; Sangoi AR; Liu PS; Umar S; Mehra R; Zhang X; Cox RM; McKenney JK
    Am J Surg Pathol; 2018 Sep; 42(9):1156-1165. PubMed ID: 29851703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
    Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
    Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic features and differential diagnosis of multilocular cystic renal cell carcinoma].
    Zhang W; Li Y; Lu Q; Zhuang J; Wang Q; Zhao H; Yu W; Kang E; Feng Z
    Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):723-7. PubMed ID: 25582248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACKD-RCC)-like Cysts.
    Sun Y; Argani P; Tickoo SK; Epstein JI
    Am J Surg Pathol; 2018 Oct; 42(10):1396-1401. PubMed ID: 30001236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
    Trpkov K; Hes O; Williamson SR; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Gill AJ
    Mod Pathol; 2021 Jul; 34(7):1392-1424. PubMed ID: 33664427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.
    Williamson SR; Halat S; Eble JN; Grignon DJ; Lopez-Beltran A; Montironi R; Tan PH; Wang M; Zhang S; Maclennan GT; Baldridge LA; Cheng L
    Am J Surg Pathol; 2012 Oct; 36(10):1425-33. PubMed ID: 22982885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary Characterization and Recategorization of Adult Unclassified Renal Cell Carcinoma.
    Kwon R; Argani P; Epstein JI; Lombardo KA; Wang X; Pierorazio PM; Mehra R; Matoso A
    Am J Surg Pathol; 2021 Apr; 45(4):450-462. PubMed ID: 33239504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
    Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
    Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
    Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
    [No Abstract]   [Full Text] [Related]  

  • 15. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.
    Bhindi B; Thompson RH; Lohse CM; Mason RJ; Frank I; Costello BA; Potretzke AM; Hartman RP; Potretzke TA; Boorjian SA; Cheville JC; Leibovich BC
    Eur Urol; 2018 Oct; 74(4):489-497. PubMed ID: 30017400
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Argani P; Matoso A; Baraban EG; Epstein JI; Antonescu CR
    Int J Surg Pathol; 2023 Jun; 31(4):409-414. PubMed ID: 36591911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fumarate hydratase-deficient renal cell carcinoma: A clinicopathological study of seven cases including hereditary and sporadic forms.
    Kuroda N; Tsutsui M; Iguchi M; Nobuoka E; Uehara T; Sonobe Y; Morinaga Y; Shibuya S; Oda W; Yanai H; Kawada C; Karashima T; Yamasaki I; Inoue K; Nagashima Y
    Ann Diagn Pathol; 2020 Dec; 49():151599. PubMed ID: 32977234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Entities in Renal Neoplasia.
    Mehra R; Smith SC; Divatia M; Amin MB
    Surg Pathol Clin; 2015 Dec; 8(4):623-56. PubMed ID: 26612218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic spectrum of cysts in end-stage kidneys: possible precursors to renal neoplasia.
    Hosseini M; Antic T; Paner GP; Chang A
    Hum Pathol; 2014 Jul; 45(7):1406-13. PubMed ID: 24775605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on selected renal cell tumors with clear cell features. With emphasis on multilocular cystic clear cell renal cell carcinoma.
    Montironi R; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Cheng L
    Histol Histopathol; 2013 Dec; 28(12):1555-66. PubMed ID: 23893851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.